{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:52:59Z","timestamp":1770918779393,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jad.2017.08.061","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T18:02:10Z","timestamp":1504202530000},"page":"313-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Attitudes toward placebo-controlled clinical trials among depressed patients in Japan"],"prefix":"10.1016","volume":"225","author":[{"given":"Norio","family":"Sugawara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Ishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Tsuchimine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Tsuruga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Tarakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanako","family":"Furukori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Nakagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Yasui-Furukori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.08.061_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-859X-10-2","article-title":"Guidelines for rating Global Assessment of Functioning (GAF)","volume":"10","author":"Aas","year":"2011","journal-title":"Ann. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2017.08.061_bib2","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.jad.2017.08.061_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.genhosppsych.2016.05.004","article-title":"A comparative study with depressed patients on the acceptability of placebo use","volume":"41","author":"Feffer","year":"2016","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2017.08.061_bib4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archpsyc.60.5.458","article-title":"Placebo or active control trials of antipsychotic drugs?","volume":"60","author":"Fleischhacker","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.08.061_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jad.2013.10.002","article-title":"Duration of untreated illness and outcomes in unipolar depression: a systematic review and meta-analysis","volume":"152\u2013154","author":"Ghio","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.08.061_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jad.2015.01.014","article-title":"Duration of untreated depression influences clinical outcomes and disability","volume":"175","author":"Ghio","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2017.08.061_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4088\/JCP.v64n0308","article-title":"Attitudes of patients with schizophrenia toward placebo-controlled clinical trials","volume":"64","author":"Hummer","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.08.061_bib8","first-page":"168","article-title":"Lifetime prevalence and age-of-onset distributions of mental disorders in the World health organization's World Mental health survey Initiative","volume":"6","author":"Kessler","year":"2007","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2017.08.061_bib9","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.jad.2017.08.061_bib10","first-page":"2811","article-title":"The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan","volume":"11","author":"Kudo","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.jad.2017.08.061_bib11","first-page":"132","article-title":"Ethical and scientific perspectives of placebo controlled trials in schizophrenia","volume":"1","author":"Melamed","year":"2009","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.jad.2017.08.061_bib12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projectio s of mortality and disability by cause 1990\u20132020: global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jad.2017.08.061_bib13","doi-asserted-by":"crossref","first-page":"e011012","DOI":"10.1136\/bmjopen-2015-011012","article-title":"Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey","volume":"6","author":"Ortiz","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jad.2017.08.061_bib14","first-page":"8","article-title":"Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III)","volume":"5","author":"Pater","year":"2004","journal-title":"Curr. Control. Trials Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.jad.2017.08.061_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/jamapsychiatry.2015.1335","article-title":"Association between placebo-activated neural systems and antidepressant responses: neurochemistry of placebo effects in major depression","volume":"72","author":"Peci\u00f1a","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2017.08.061_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2017.08.061_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jpsychires.2012.02.008","article-title":"Contribution of spontaneous improvement to placebo response in depression: a meta-analytic review","volume":"46","author":"Rutherford","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.jad.2017.08.061_bib18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4088\/JCP.12r08267","article-title":"Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout","volume":"74","author":"Rutherford","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.08.061_bib19","unstructured":"Subcommittee on Placebo-controlled Studies, 2016. Pharmaceutical and Medical Devices Agency. Current Status and Perspectives of Placebo-controlled Studies. \u3008https:\/\/www.pmda.go.jp\/files\/000212279.pdf\u3009."},{"issue":"11","key":"10.1016\/j.jad.2017.08.061_bib20","doi-asserted-by":"crossref","first-page":"e0143356","DOI":"10.1371\/journal.pone.0143356","article-title":"Attitudes toward placebo-controlled clinical trials of patients with schizophrenia in Japan","volume":"10","author":"Sugawara","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2017.08.061_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000198167","article-title":"Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'?","volume":"17","author":"Su","year":"2009","journal-title":"Neurosignals"},{"issue":"585","key":"10.1016\/j.jad.2017.08.061_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3399\/bjgp11X567036","article-title":"Involving patients with depression in research: survey of patients' attitudes to participation","volume":"61","author":"Tallon","year":"2011","journal-title":"Br. J. Gen. Pract."},{"issue":"3","key":"10.1016\/j.jad.2017.08.061_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/NMD.0b013e318247d24f","article-title":"Ethical issues of placebo-controlled studies in depression and a randomized withdrawal trial in Japan: case study in the ethics of mental health research","volume":"200","author":"Tashiro","year":"2012","journal-title":"J. Nerv. Ment. Dis."},{"issue":"5","key":"10.1016\/j.jad.2017.08.061_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40596-015-0470-2","article-title":"Psychiatrists' attitudes toward non-pharmacologic factors within the context of antidepressant pharmacotherapy","volume":"40","author":"Vijapura","year":"2016","journal-title":"Acad. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2017.08.061_bib25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1017\/S0033291712001717","article-title":"Estimating remission from untreated major depression: a systematic review and meta-analysis","volume":"43","author":"Whiteford","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2017.08.061_bib26","unstructured":"World Health Organization, 2001. The world health report - Mental Health: New Understanding, New Hope. Available from \u3008http:\/\/www.who.int\/whr\/2001\/en\/\u3009 (accessed 31 March 2012)."},{"key":"10.1016\/j.jad.2017.08.061_bib27","unstructured":"World Medical Association, 2013. Declaration of Helsinki: Ethical Principles for Medical Research. Involving Human Subjects. Fortaleza, Brazil. WMA. Available at: \u3008http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/\u3009."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717309011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717309011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:19:28Z","timestamp":1759022368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717309011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":27,"alternative-id":["S0165032717309011"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.08.061","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attitudes toward placebo-controlled clinical trials among depressed patients in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}